AACC Statement on Exclusion of VALID Act from Omnibus Bill
AACC issued a statement supporting the U.S. Congress’ exclusion of the VALID Act from its 2023 Omnibus Bill.
Read MorePosted by Chris Wolski | Dec 27, 2022 | Compliance, Diagnostic Technologies, Miscellaneous |
AACC issued a statement supporting the U.S. Congress’ exclusion of the VALID Act from its 2023 Omnibus Bill.
Read MorePosted by Chris Wolski | Dec 26, 2022 | Compliance, Miscellaneous |
The Association of Medical Pathology (AMP) applauded Congress for not including the VALID Act in the Consolidated Appropriations Act of 2023.
Read MorePosted by Chris Wolski | Dec 23, 2022 | Calibrators |
Verichem Laboratories now offers ready-to-use, liquid stable clinical reference materials for Total Cholesterol, HDL, and LDL testing.
Read MorePosted by Andy Lundin | Dec 15, 2022 | Prostate |
Researchers pioneered and implemented a novel algorithm to provide genetic testing to patients with newly diagnosed prostate cancer.
Read MorePosted by Andy Lundin | Dec 13, 2022 | Compliance |
The AACC is urging clinical lab professionals to write to their legislators to keep the VALID Act out of a Fiscal Year 2023 budget agreement.
Read More